Retatrutide Outperforms Semaglutide in Phase 3 A1C and Weight Results | Retatrutide News

Retatrutide showed better A1C reduction and weight loss than semaglutide 2 mg in an 80-week Phase 3 trial. This suggests retatrutide could be a more eff...
Clinical Trials · October 29, 2026